Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2026-01-03 @ 3:04 PM
Study NCT ID:
NCT01023958
Status:
COMPLETED
Last Update Posted:
2017-11-22
First Post:
2009-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-11-19
Start Date Type:
ACTUAL
Primary Completion Date:
2011-09-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-09-19
Completion Date Type:
ACTUAL
First Submit Date:
2009-11-24
First Submit QC Date:
None
Study First Post Date:
2009-12-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-10-23
Results First Submit QC Date:
None
Results First Post Date:
2017-11-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-05-16
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-10-23
Last Update Post Date:
2017-11-22
Last Update Post Date Type:
ACTUAL